PATENT CLAIM ANALYSIS

Application Number: 15987011
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "009100"]

Abstract:
S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.

Claim (Index 29):
The method according to  claim 25 , wherein fingolimod is administered as a hydrochloride salt.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.07143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15986992', '15534929', '12655049', '13640857', '14973105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6976337761894359
- 35 USC 102 Novelty (BERT): 0.5609652768005466
- Combined Prediction Score: 0.683966926250547
- Mean Citation Score: 276.313602
- Max Citation Score: 427.91425
- Similarity Product: 322.24321051883703

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test